Use cases · six personas

How drug development teams use Brioche.

Six scenes from the work. The question each persona arrives with, and the brief the practice writes back. Pick one — each opens its own page.

Built forDrug development teams

Engagement modelProject & continuous

PostureNDA-default

Index

Six questions we hear most often.

01 Clinical-stage CEO "Will my IND get a CRL? Who is beating me to the indication?" Continuous Intelligence Retainer → 02 Pharma R&D Director "Is this target worth pursuing? What has already failed in this indication?" Discovery Diligence → 03 BD & Strategy Lead "Should we license this? What does the comparator set actually look like?" Discovery Diligence (one-shot) → 04 Regulatory Affairs Head "What deficiencies has FDA cited on similar submissions?" Regulatory Intelligence Report → 05 Precision medicine lead "For this patient with this mutation profile, what is the best-ranked therapeutic — and if nothing fits, what analog should we propose?" Patient-context engagement · molecular tumor board / specialty clinic → 06 Investor diligence "A buy-side question on a target asset. Selectively, where the question is well-formed." Discovery Diligence (selective) →